Empowering scientists to work on the riskiest, most exciting ideas.
Empowering scientists to work on the riskiest, most exciting ideas.

Empowering scientists to work on the riskiest, most exciting ideas.

The Chan Zuckerberg Biohub is an independent, nonprofit research center that is working to cure, prevent, or manage all disease by the end of the century.

a partnership between

Empowering scientists to work on the riskiest, most exciting ideas. Empowering scientists to work on the riskiest, most exciting ideas.

Many diseases are caused by disorders of the cell. That’s why we support rigorous, quantitative research in
see it in action
cell biology.

Quantitative Cell Science
Tabula Sapiens – A First-Draft Single-Cell Transcriptomic Atlas of 2 Human Donors, 14 Organs, and 150,000 Cells

This collaborative project provides a molecular characterization of cellular diversity in the human body.

EXPLORE THE DATA
Quantitative Cell Science
OpenCell – A Collection of Localization and Interactome Measurements for Human Proteins

A collaboration between the Leonetti group at CZ Biohub and the Mann Lab at the Max Planck Institute for Biochemistry, along with many other colleagues.

VISIT OPENCELL

Because existing and emerging pathogens continue to threaten human health worldwide, we create and deploy systems to detect and respond to
see it in action
infectious disease globally.

INFECTIOUS DISEASE
IDseq – Identifying Pathogens in Metagenomic Sequencing Data

IDseq is a real-time pathogen detection dashboard that helps prevent disease outbreaks around the world. It was created in partnership with scientists and engineers from the Chan Zuckerberg Initiative.

LEARN MORE
INFECTIOUS DISEASE
COVID Tracker – The Open-Source Web Platform for COVID-19

CZ Biohub is providing free whole genome sequencing, analysis, and interpretation of SARS-CoV-2 to support the pandemic response. All California Departments of Public Health are invited to participate.

LEARN MORE
INVESTIGATOR PROGRAM
Markita Landry – Developing New Nanosensor Technology and Near-Infrared Imaging Platforms

Markita's work includes targeting specific neural circuits in vivo, and supporting closed-loop monitoring and manipulation of neural circuits

LEARN MORE ABOUT OUR INVESTIGATOR PROGRAM

We support high-risk research programs that might otherwise not be funded by conventional sources, and we support the training of the next-generation of scientists and physician-scientists through competitive fellowship programs.

INVESTIGATOR TEAM AWARDS
CZ Biohub Team Award – Defining Host Responses of Virus-Infected and Uninfected Neighbor Cells

The team will focus on how RNA transmission, alterations in viral and cellular RNA stability, and nutritional status can elicit pro- or anti-viral responses in neighbors, drawing on their expertise in culturing 3D human organoids to provide realistic models for the complex interactions that occur between cells in human tissue.

LEARN MORE ABOUT OUR INTERCAMPUS RESEARCH AWARDS
IN THE NEWS
Dr. Joe DeRisi in his lab at the CZ Biohub
60 Minutes – Doctors, Scientists Who Warned Officials About Oncoming Pandemic Focus of New Michael Lewis Book

In his new book, Michael Lewis profiles people who tried to sound the alarm about COVID-19 as officials failed to act – including CZ Biohub Co-President Dr. Joe DeRisi.

WATCH
IN THE NEWS
The New York Times – The Disease Detective

CZ Biohub co-president Joe DeRisi invented a way to find pathogens that scientists didn’t even know to look for. Can it help prevent the next pandemic?

READ MORE
FEATURED PUBLICATIONS
High-Resolution, Large Imaging Volume, and Multi-View Single Objective Light-Sheet Microscopy Icon

High-Resolution, Large Imaging Volume, and Multi-View Single Objective Light-Sheet Microscopy

READ NOW OpenCell: Proteome-Scale Endogenous Tagging Enables the Cartography of Human Cellular Organization Icon

OpenCell: Proteome-Scale Endogenous Tagging Enables the Cartography of Human Cellular Organization

READ NOW Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco Icon

Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco

READ NOW